Even activity on this board shows people lost enthusiasm for ACUR. Most of shareholders are now wondering what will be reported on Friday, as they are left to the mercy of management that is mute, and has been mute for over 3 months. Nothing good will come out of Q2 CC.
I assume there will be good news on Nexafed. Defeating the one pot method is huge.
I do not understand why the stock has not reacted to that announcement.
Of course money was spent, but a fantastic result was produced. Should be all good on the Nexafed front. Oxecta......probably not so much.